ACTRN12621001013853RecruitingPhase 2
Acetylcysteine in Adults with Bronchiectasis: A feasibility pilot study assessing, anti-inflammatory and clinical effects.
Western Health Foundation0 sites30 target enrollmentStarted: August 4, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 18 Years to 80 Years (—)
- Sex
- All
Inclusion Criteria
- •bronchiectasis
Exclusion Criteria
- •current smokers, those with greater than 20 pack year history, cystic fibrosis, non tuberculous mycobacterial infection.
Investigators
Similar Trials
Completed
Not Applicable
High Concentration Oxygen in Bronchiectasis or Cystic Fibrosis: Study 2Respiratory - Other respiratory disorders / diseasesBronchiectasisCystic FibrosisACTRN12615000971538Janine Pilcher24
Unknown
Phase 4
Nebulized N-Acetyl Cysteine for Bronchiolitis in Inpatient Hospital UseBronchiolitis AcuteNCT03364218Carilion Clinic106
Terminated
Phase 4
The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung FunctionCystic FibrosisNCT00996424University Hospital, Ghent19
Terminated
Phase 4
The prevention of airway narrowing following dry powder mannitol inhalation in susceptible bronchiectatic patientsPrevention of airway narrowing in bronchiectatic patients following inhalation of dry powder mannitolRespiratory - AsthmaACTRN12607000379415Sydney South West Area Health Service25
Recruiting
Not Applicable
acetylcysteine in heavy smokers: A double-blind randomized controlled trial.nicotine dependenceNL-OMON21561Academic Medical Center (AMC)20